Management of life-threatening epistaxis in a Jehovah's Witness. | Canada Hyperbarics Skip to main content
Clinical Study International journal of clinical practice 2003

Management of life-threatening epistaxis in a Jehovah's Witness.

Stark RD, Coatesworth AP, Tucker AG — International journal of clinical practice, 2003

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reported a case of life-threatening epistaxis in a Jehovah's Witness patient.

What They Found

They found that a Jehovah's Witness patient presented with life-threatening epistaxis, leading to severe anaemia with a haemoglobin level of 2.7 g/dl. Despite the patient's religious beliefs forbidding blood transfusions, the case was successfully managed.

Canadian Relevance

This study has no direct Canadian connection as it was not conducted in Canada or by Canadian researchers.

Study Limitations

A significant limitation of this study is that it is a single case report, which limits the generalizability of its findings to a broader patient population.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Severe-anemia
Source Pubmed
PubMed ID 12587946
Year Published 2003
Journal International journal of clinical practice
MeSH Terms Anemia; Critical Illness; Epistaxis; Female; Humans; Hyperbaric Oxygenation; Jehovah's Witnesses; Middle Aged; Treatment Refusal

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology